BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1466 related articles for article (PubMed ID: 16760442)

  • 21. Biology and treatment of Burkitt's lymphoma.
    Yustein JT; Dang CV
    Curr Opin Hematol; 2007 Jul; 14(4):375-81. PubMed ID: 17534164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
    Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
    Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
    Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
    Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus.
    Wilda M; Busch K; Klose I; Keller T; Woessmann W; Kreuder J; Harbott J; Borkhardt A
    Genes Chromosomes Cancer; 2004 Oct; 41(2):178-82. PubMed ID: 15287031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
    Bürgesser MV; Gualco G; Diller A; Natkunam Y; Bacchi CE
    Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Several lymphoma-specific genetic events in parallel can be found in mature B-cell neoplasms.
    Bacher U; Haferlach T; Alpermann T; Kern W; Schnittger S; Haferlach C
    Genes Chromosomes Cancer; 2011 Jan; 50(1):43-50. PubMed ID: 20960563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
    Mationg-Kalaw E; Tan LH; Tay K; Lim ST; Tang T; Lee YY; Tan SY
    Histopathology; 2012 Dec; 61(6):1214-8. PubMed ID: 23171357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions.
    Haralambieva E; Schuuring E; Rosati S; van Noesel C; Jansen P; Appel I; Guikema J; Wabinga H; Bleggi-Torres LF; Lam K; van den Berg E; Mellink C; van Zelderen-Bhola S; Kluin P
    Genes Chromosomes Cancer; 2004 May; 40(1):10-8. PubMed ID: 15034863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.
    Boerma EG; Siebert R; Kluin PM; Baudis M
    Leukemia; 2009 Feb; 23(2):225-34. PubMed ID: 18923440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-grade mature B-cell lymphoma with Burkitt-like morphology: results of a clinicopathological study of 72 Japanese patients.
    Nomura Y; Karube K; Suzuki R; Ying G; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
    Cancer Sci; 2008 Feb; 99(2):246-52. PubMed ID: 18271922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation.
    Sevilla DW; Gong JZ; Goodman BK; Buckley PJ; Rosoff P; Gockerman JP; Lagoo AS
    Am J Clin Pathol; 2007 Dec; 128(6):981-91. PubMed ID: 18024324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular background of aggressive B cell lymphomas as a basis for targeted therapy.
    de Jong D; Balagué Ponz O
    J Pathol; 2011 Jan; 223(2):274-82. PubMed ID: 21125680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.
    Aukema SM; Kreuz M; Kohler CW; Rosolowski M; Hasenclever D; Hummel M; Küppers R; Lenze D; Ott G; Pott C; Richter J; Rosenwald A; Szczepanowski M; Schwaenen C; Stein H; Trautmann H; Wessendorf S; Trümper L; Loeffler M; Spang R; Kluin PM; Klapper W; Siebert R;
    Haematologica; 2014 Apr; 99(4):726-35. PubMed ID: 24179151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma.
    Dierlamm J; Murga Penas EM; Bentink S; Wessendorf S; Berger H; Hummel M; Klapper W; Lenze D; Rosenwald A; Haralambieva E; Ott G; Cogliatti SB; Möller P; Schwaenen C; Stein H; Löffler M; Spang R; Trümper L; Siebert R;
    Haematologica; 2008 May; 93(5):688-96. PubMed ID: 18367485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation.
    Ruzinova MB; Caron T; Rodig SJ
    Am J Surg Pathol; 2010 Jun; 34(6):882-91. PubMed ID: 20442643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation.
    Rodig SJ; Vergilio JA; Shahsafaei A; Dorfman DM
    Am J Surg Pathol; 2008 Jan; 32(1):113-22. PubMed ID: 18162778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.
    Bellan C; Stefano L; Giulia de F; Rogena EA; Lorenzo L
    Hematol Oncol; 2010 Jun; 28(2):53-6. PubMed ID: 19844983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
    Bemark M; Neuberger MS
    Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomorphologic findings of B-cell lymphomas with concurrent IGH/BCL2 and MYC rearrangements (dual-translocation lymphomas).
    da Cunha Santos G; Ko HM; Saieg MA; Boerner SL; Lai SW; Bailey D; Geddie WR
    Cancer Cytopathol; 2011 Aug; 119(4):254-62. PubMed ID: 21560251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 74.